Short latency afferent inhibition in Parkinsons disease patients with dementia
Movement Disorders, 06/08/2012Celeb O et al.
The findings add further evidence that differential cholinergic deficiency occurs in Parkinson's disease (PD) and PD dementia (PDD). Short-latency afferent inhibition (SAI)can be a neurophysiological correlate of PDD.
SAI and neuropsychological profile were studied in nondemented PD, PDD, Alzheimer's disease (AD) patients, and age-matched controls.
SAI was significantly impaired in AD cases (94.7 ± 6.2 versus 55.5 ± 4.0; P<0.0001).
In PD patients, it was not different from controls (61.4 ± 5.8 versus 55.5 ± 4.0; P=0.412).
PDD cases demonstrated a significant impairment in SAI (91.4 ± 5.2 versus 55.5 ± 4.0; P<0.0001).
A high correlation was found between SAI and Mini–Mental State Examination (r=-0.68; P<0.0001).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.